| Product Code: ETC13117602 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Finland saw a significant volume of pneumococcal vaccines imported, with top exporting countries being the USA, Germany, UK, Austria, and New Zealand. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite the impressive compound annual growth rate (CAGR) of 24.17% from 2020 to 2024, there was a notable decline in the growth rate from 2023 to 2024 at -20.18%. This fluctuation suggests a dynamic market environment for pneumococcal vaccines in Finland, influenced by various factors impacting import trends.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Pneumococcal Vaccines Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Finland Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Finland Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Finland Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Finland Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Finland Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Finland Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination for preventing pneumococcal diseases |
4.2.2 Government initiatives to promote immunization programs |
4.2.3 Rising prevalence of pneumococcal infections in Finland |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Vaccine hesitancy among certain population groups |
5 Finland Pneumococcal Vaccines Market Trends |
6 Finland Pneumococcal Vaccines Market, By Types |
6.1 Finland Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Finland Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Finland Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Finland Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Finland Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Finland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Finland Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Finland Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Finland Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Finland Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Finland Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Finland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Finland Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Finland Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Finland Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Finland Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Finland Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Finland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Finland Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Finland Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Finland Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Finland Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Finland Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Finland Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Finland Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Finland Pneumococcal Vaccines Market Export to Major Countries |
7.2 Finland Pneumococcal Vaccines Market Imports from Major Countries |
8 Finland Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates among the target population |
8.2 Number of healthcare facilities offering pneumococcal vaccination services |
8.3 Rate of decline in pneumococcal infection cases in Finland |
9 Finland Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Finland Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Finland Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Finland Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Finland Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Finland Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Finland Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Finland Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here